ROYAL BANK OF CANADA - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 41 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
247
-47.7%
0.00%
Q2 2023$1,000472
+673.8%
0.00%
Q1 2023$061
+1425.0%
0.00%
Q4 2022$04
-94.8%
0.00%
Q3 2022$0
-100.0%
77
-94.0%
0.00%
Q1 2022$3,000
-88.5%
1,284
-70.4%
0.00%
Q4 2021$26,000
+4.0%
4,343
+80.1%
0.00%
Q3 2021$25,000
+257.1%
2,411
+255.1%
0.00%
Q2 2021$7,000
-36.4%
679
-7.6%
0.00%
Q1 2021$11,0007350.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Newtyn Management, LLC 1,800,000$1,350,1800.33%
Deuterium Capital Management, LLC 11,000$8,8000.02%
Duquesne Family Office 100,000$800.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 112,900$84,6860.00%
RAYMOND JAMES & ASSOCIATES 14,000$11,2000.00%
TWO SIGMA INVESTMENTS, LP 10,876$8,7010.00%
BANK OF AMERICA CORP /DE/ 90,774$72,6190.00%
WELLS FARGO & COMPANY/MN 132$1060.00%
NORTHERN TRUST CORP 26,049$20,8390.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders